GSE205714 GSE229013 adenosine 3 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE205714_GSE229013_adenosine_3_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE205714_GSE229013_adenosine_3_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE205714_GSE229013_adenosine_3_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE205714_GSE229013_adenosine_3_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

uncharaterized LOC112694756

Gene

ribosomal protein SA 2

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

mitochondrial rRNA methyltransferase 1

Gene

VPS9D1 antisense RNA 1

Gene

NSUN5 pseudogene 1

Gene

WASP family homolog 5, pseudogene

Gene

TMEM147 antisense RNA 1

Gene

family with sequence similarity 27 member C

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    uncharaterized LOC112694756


  • Gene

    ribosomal protein SA 2


  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    mitochondrial rRNA methyltransferase 1


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    NSUN5 pseudogene 1


  • Gene

    WASP family homolog 5, pseudogene


  • Gene

    TMEM147 antisense RNA 1


  • Gene

    family with sequence similarity 27 member C

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.